Results 181 to 190 of about 4,559,446 (271)
Some of the next articles are maybe not open access.

Melanonychia associated with PUVA therapy

Journal of the American Academy of Dermatology, 2003
We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S, Ledbetter, Sylvia, Hsu
openaire   +2 more sources

PUVA therapy in lichen aureus

Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire   +2 more sources

Dose Measurement in PUVA Therapy

Dermatology, 1979
The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire   +2 more sources

PUVA therapy.

American family physician, 1991
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm   +3 more
openaire   +1 more source

Onycholysis occurring during PUVA therapy

Clinical and Experimental Dermatology, 1979
Summary A patient with mycosis fungoides developed onycholysis of all finger nails during photo-chemotherapy (PUVA). After shielding of the nails during UVA exposure normal regrowth was observed. Photo-onycholysis has been recognized for many years as a possible sequel to cutaneous photosensitization complicating therapy with ...
openaire   +2 more sources

Leukoderma punctatum following systemic PUVA therapy

International Journal of Dermatology, 2002
A 35‐year‐old woman with vitiligo vulgaris had been treated with psoralen plus UVA (PUVA) therapy for 15 months. She was given 4,5′,8‐trimethylpsoralen (0.6 mg/kg 3 days/week) and UVA exposure (UV 7001 K Waldmann PUVA chamber). She developed repigmentation over more than 50% of the vitiliginous area over a period of 1 year.
Sunil, Dogra   +3 more
openaire   +2 more sources

Lymphocyte proliferation during PUVA therapy

Archives of Dermatological Research, 1979
The lymphocyte proliferation of 15 psoriatic patients was sutdied after stimulation with tuberculin, trichophytin, varidase, concanavalin A (Con A), and pokeweek mitogen (PMW) during the first and the eighth PUVA treatment, 2 h after oral intake of 8-methoxypsoralen (8-MOP), immediately after UVA-irradiation, and 24 h later.
openaire   +2 more sources

PUVA therapy of diffuse granuloma annulare

Clinical and Experimental Dermatology, 1988
3 cas de granulome annulaire diffus interessant 20 a 40% de la surface corporelle et de duree variable ont ete traites par la PUVAtherapie.
T C, Hindson, J G, Spiro, H, Cochrane
openaire   +2 more sources

Position paper—PUVA therapy

Journal of the American Academy of Dermatology, 1983
PUVA, the combination of psoralen (P) and long-wave ultraviolet radiation (UVA), is being used increasingly in the management of psoriasis and several other dermatologic disorders. While the acute toxicity of this modality, which includes erythema and blistering of the skin, can be avoided with careful monitoring of the dosimetry of the administered ...
openaire   +1 more source

PUVA therapy and the lens reconsidered

Documenta Ophthalmologica, 1988
On the basis of animal experiments there appears to be a theoretical chance that lens changes will occur in patients receiving PUVA treatment. In the published studies the incidence of lens changes in patients treated with PUVA is very low. In this study changes were observed both during PUVA treatment and during a long follow-up period. The absence of
W L, Van Deenen, W P, Lamers
openaire   +2 more sources

Home - About - Disclaimer - Privacy